|
|
Prerequisite to purchase this online program: Visceral Manipulation 1 seminar. Online Video - streaming video for your computer or digital device - available exclusively through IAHE. NOTE: After purchase of this program, you will receive an in-depth overview of the online experience and full access to the online self-paced learning modules, quizzes and Q&A with Ron Mariotti. Online Video-Visceral Manipulation: Advanced Clinical Applications for Common Gastrointestinal Issues - 3 - Virtual Component This virtual program (CG3) will strengthen the participant’s expertise in integrating Barral’s Visceral Manipulation techniques with common gastrointestinal issues as seen in the clinical practice. The focus of this class is the abdominal organs including the pancreas, spleen and kidney. The participants will gain a deeper understanding of each organ including their associated membranes, ligaments, innervation, vascularization, spatial and functional interrelationships, and a deep-dive into organ physiology and common organ pathologies seen in the manual therapy practice. The online program includes up to 3 months access of webinars and self-paced modules. Taking a deliberate path through all the material, including the quizzes, is approximately 20 hours of coursework. ~ Webinars (2) with Dr Mariotti ~ Self-Paced Modules If you need CEUs for this virtual program, please request them in advance by contacting iahe@iahe.com or 561.622.4334 ext 2. Goals of the full Series: ⁃ Increased understanding of the anatomical and physiological basis of Barral’s VM techniques. ⁃ Detailed understanding of organ evolution, embryology, anatomy, and physiology. ⁃ Deeper understanding of organ/brain connections. ⁃ Detailed understanding of common presentations of visceral pathology seen in clinical practice. ⁃ Deeper understanding of organ connections via fascial, vascular, neural, hormonal, and chemical pathways. ⁃ Provide participants with a pathology-specific protocol based on organ-organ and organ-brain interconnections to optimize patient outcomes.
|
|
|
|
